News

NUS scientists use AI platform to improve effectiveness of Covid-19 drugs against Omicron

Prof Dean Ho found that when antiviral drugs molnupiravir and Paxlovid were each combined with the protease-inhibiting drug YH-53, the mix was effective against the Omicron variant of the coronavirus in lab settings. He used his AI platform, known as IDentif.AI, to determine the combination and dosage.

Read more: https://www.straitstimes.com/singapore/nus-scientists-leverage-ai-platform-to-improve-effectiveness-of-covid-19-drugs-against-omicron

view MORE related

News

2024
AI will have to proof itself to gain greater traction in healthcare sector, say industry player
More Details >
2024
For intermittent fasters, 4 protein-rich meals can help you stay full and energized on the go
More Details >
2024
Harnessing AI to see a patient’s unique patterns
More Details >
get in touch and

Contact Us

For inquiries pertaining to our R&D Programs, please contact Khew Si Ying at khewsiying@nus.edu.sg

The Institute for Digital Medicine (WisDM)

  • 28 Medical Drive, #05-COR,
    Singapore 117456

© National University of Singapore. All Rights Reserved.